|
|---|
|
Khan SA,
Burke M,
Zhu F,
Yang DH,
Dubyk C,
Mehra R,
Lango MJ,
Ridge JA,
Sher DJ,
Burtness B. Survivin expression and impact on head and neck cancer outcomes.
Oral Oncol. 2021 Jan;112
:105049. |
|
Khan SA,
Burke M,
Zhu F,
Yang DH,
Dubyk C,
Mehra R,
Lango MJ,
Ridge JA,
Sher DJ,
Burtness B. Survivin expression and impact on head and neck cancer outcomes.
Oral Oncol. 2020 Nov 19;112
:105049. |
|
Lee JW,
Parameswaran J,
Sandoval-Schaefer T,
Eoh KJ,
Yang DH,
Zhu F,
Mehra R,
Sharma R,
Gaffney SG,
Perry EB,
Townsend JP,
Serebriiskii IG,
Golemis EA,
Issaeva N,
Yarbrough WG,
Koo JS,
Burtness BA. Combined Aurora kinase A (AURKA) and WEE1 inhibition demonstrates synergistic antitumor effect in squamous cell carcinoma of the head and neck.
Clin Cancer Res. 2019 Jun 1;25(11)
:3430-3442. PMC ID:PMC6548643. |
|
Eze N,
Lee JW,
Yang DH,
Zhu F,
Neumeister V,
Sandoval-Schaefer T,
Mehra R,
Ridge JA,
Forastiere A,
Chung CH,
Burtness B. PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma.
Oral Oncol. 2019 Apr;91
:69-78. PMC ID:PMC6855599. |
|
Kudinov AE,
Deneka A,
Nikonova AS,
Beck TN,
Ahn YH,
Liu X,
Martinez CF,
Schultz FA,
Reynolds S,
Yang DH,
Cai KQ,
Yaghmour KM,
Baker KA,
Egleston BL,
Nicolas E,
Chikwem A,
Andrianov G,
Singh S,
Borghaei H,
Serebriiskii IG,
Gibbons DL,
Kurie JM,
Golemis EA,
Boumber Y. Musashi-2 (MSI2) supports TGF-beta signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis.
Proc Natl Acad Sci U S A. 2016 Jun 21;113(25)
:6955-60. PMC ID:PMC4922167. |
|
Gabitova L,
Restifo D,
Gorin A,
Manocha K,
Handorf E,
Yang DH,
Cai KQ,
Klein-Szanto AJ,
Cunningham D,
Kratz LE,
Herman GE,
Golemis EA,
Astsaturov I. Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR.
Cell Rep. 2015 Sep 22;12(11)
:1927-38. PMC ID:PMC4581991. |
|
Liu DL,
Li YJ,
Yang DH,
Wang CR,
Xu J,
Yao N,
Zhang XQ,
Chen ZS,
Ye WC,
Zhang DM. Ganoderma lucidum derived ganoderenic acid B reverses ABCB1-mediated multidrug resistance in HepG2/ADM cells.
Int J Oncol. 2015 May;46(5)
:2029-38. |
|
Cai KQ,
Wang Y,
Smith ER,
Smedberg JL,
Yang DH,
Yang WL,
Xu XX. Global deletion of Trp53 reverts ovarian tumor phenotype of the germ cell-deficient white spotting variant (wv) mice.
Neoplasia. 2015 Jan;17(1)
:89-100. PMC ID:PMC4309726. |
|
Wang DS,
Patel A,
Shukla S,
Zhang YK,
Wang YJ,
Kathawala RJ,
Robey RW,
Zhang L,
Yang DH,
Talele TT,
Bates SE,
Ambudkar SV,
Xu RH,
Chen ZS. Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2.
Oncotarget. 2014 Jun 30;5(12)
:4529-42. PMC ID:PMC4147343. |
|
Sodani K,
Patel A,
Anreddy N,
Singh S,
Yang DH,
Kathawala RJ,
Kumar P,
Talele TT,
Chen ZS. Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo.
Biochem Pharmacol. 2014 May 1;89(1)
:52-61. |
|
Mehra R,
Zhu F,
Yang DH,
Cai KQ,
Weaver J,
Singh MK,
Nikonova AS,
Golemis EA,
Flieder DB,
Cooper HS,
Lango M,
Ridge JA,
Burtness B. Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancers.
Clin Cancer Res. 2013 Dec 1;19(23)
:6633-43. |
|
Jiang WD,
Huang RC,
Duan CH,
Fu LW,
Xi Y,
Yang YB,
Yang WM,
Yang DZ,
Yang DH,
Huang RP. Identification of Five Serum Protein Markers for Detection of Ovarian Cancer by Antibody Arrays.
Plos One. 2013 Oct;8(10)
:e76795. PMC ID:PMC 3792870. |
|
Chen JJ,
Patel A,
Sodani K,
Xiao ZJ,
Tiwari AK,
Zhang DM,
Li YJ,
Yang DH,
Ye WC,
Chen SD,
Chen ZS. BBA, a Synthetic Derivative of 23-hydroxybutulinic Acid, Reverses Multidrug Resistance by Inhibiting the Efflux Activity of MRP7 (ABCC10).
PLoS One. 2013 Sep;8(9)
:e74573. PMC ID:PMC 3775757. |
|
Peri S,
Devarajan K,
Yang DH,
Knudson AG,
Balachandran S. Meta-Analysis Identifies NF-kappaB as a Therapeutic Target in Renal Cancer.
PLoS One. 2013 ;8(10)
:e76746. |
|
Sukhanova A,
Gorin A,
Serebriiskii IG,
Gabitova L,
Zheng H,
Restifo D,
Egleston BL,
Cunningham D,
Bagnyukova T,
Liu H,
Nikonova A,
Adams GP,
Zhou Y,
Yang DH,
Mehra R,
Burtness B,
Cai KQ,
Klein-Szanto A,
Kratz LE,
Kelley RI,
Weiner LM,
Herman GE,
Golemis EA,
Astsaturov I. Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation.
Cancer Discov. 2013 Jan;3(1)
:96-111. PMC ID:PMC3546138. |
|
Shi Z,
Yang WM,
Chen LP,
Yang DH,
Zhou Q,
Zhu J,
Chen JJ,
Huang RC,
Chen ZS,
Huang RP. Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production.
Breast Cancer Research and Treatment. 2012 Oct;135(3)
:737-747. |
|
Chen JJ,
Sun YL,
Tiwari AK,
Xiao ZJ,
Sodani K,
Yang DH,
Vispute SG,
Jiang WQ,
Chen SD,
Chen ZS. PDE5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP-binding Cassette C10) transporter.
Cancer Science. 2012 Aug;103(8)
:1531-1537. |
|
Ding PR,
Tiwari AK,
Ohnuma S,
Lee JW,
An X,
Dai CL,
Lu QS,
Singh S,
Yang DH,
Talele TT,
Ambudkar SV,
Chen ZS. The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporter.
PLoS One. 2011 ;6(4)
:e19329. PMC ID:PMC3084276. |
|
Yang DH,
Smith ER,
Cai KQ,
Xu XX. c-fos Elimination Compensates for disabled-2 Requirement in Mouse Extraembryonic Endoderm. Development.
Developmental Dynamics. 2009 Mar;238(3)
:514-523. PMC ID:PMC 2743073. |
|
Cai KQ,
Capo-Chichi CD,
Rula ME,
Yang DH,
Xu XX. Dynamic GATA6 expression in primitive endoderm formation and maturation in early mouse embryogenesis.
Dev Dyn. 2008 Oct;237(10)
:2820-9. |
|
Rula ME,
Cai KQ,
Moore R,
Yang DH,
Staub CM,
Capo-Chichi CD,
Jablonski SA,
Howe PH,
Smith ER,
Xu XX. Cell autonomous sorting and surface positioning in the formation of primitive endoderm in embryoid bodies.
Genesis. 2007 Jun;45(6)
:327-38. |
|
Yang DH,
Cai KQ,
Roland IH,
Smith ER,
Xu XX. Disabled-2 is an epithelial surface positioning gene.
J Biol Chem. 2007 Apr 27;282(17)
:13114-22. |
|
Yang DH,
Fazili Z,
Smith ER,
Cai KQ,
Klein-Szanto A,
Cohen C,
Horowitz IR,
Xu XX. Disabled-2 Heterozygous Mice Are Predisposed to Endometrial and Ovarian Tumorigenesis and Exhibit Sex-Biased Embryonic Lethality in a p53-Null Background.
Am J Pathol. 2006 Jul;169(1)
:258-67. |
|
Roland IH,
Yang WL,
Yang DH,
Daly MB,
Ozols RF,
Hamilton TC,
Lynch HT,
Godwin AK,
Xu XX. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
Cancer. 2003 Dec;98(12)
:2607-2623. |
|
Yang DH,
Moss EG. Temporally regulated expression of Lin-28 in diverse tissues.
Gene Expression Patterns. 2003 Dec;3(6)
:719-726. |
|
Yang DH,
Smith ER,
Roland IH,
Sheng ZJ,
He JQ,
Martin WD,
Hamilton TC,
Lambeth JD,
Xu XX. Disabled-2 is essential for endodermal cell positioning and structure formation during mouse embryogenesis.
Developmental Biology. 2002 Nov 1 2002;251(1)
:27-44. |
|
Smedberg JL,
Smith ER,
Capo-Chichi CD,
Frolov A,
Yang DH,
Godwin AK,
Xu XX. Ras/MAPK Pathway Confers Basement Membrane Dependence upon Endoderm Differentiation of Embryonic Carcinoma Cells.
J Biol Chem. 2002 Oct 25;277(43)
:40911-8. |
|
Capo-Chichi CD,
Smith ER,
Yang DH,
Roland IH,
Vanderveer L,
Cohen C,
Hamilton TC,
Godwin AK,
Xu XX. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.
Cancer. 2002 Oct 15;95(8)
:1802-15. |
|
Yang DH,
Smith ER,
Cohen C,
Wu H,
Patriotis C,
Godwin AK,
Hamilton TC,
Xu XX. Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity.
Cancer. 2002 May 1;94(9)
:2380-92. |
|
Smith ER,
Capo-chichi CD,
He J,
Smedberg JL,
Yang DH,
Prowse AH,
Godwin AK,
Hamilton TC,
Xu XX. Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cells.
J Biol Chem. 2001 Dec 14;276(50)
:47303-10. |
|
Faculty
Publications
